{"result": {"id": "chatcmpl-613", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "The **REGARD** clinical trial was a study investigating the use of Ramucirumab as a second-line treatment option for patients with metastatic advanced gastric cancer (AGC).  This trial aimed to evaluate the effectiveness and safety of this drug in treating these specific types of cancer. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743238740, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 59, "prompt_tokens": 165, "total_tokens": 224, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"REGARD\"\nDescription List: [\"\\nClinical trial that tested Ramucirumab as second-line therapy of metastatic AGC\", \"Trial for cancer treatment\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_ff4a74eb923c230f8a13a29d1b16de4256c90d76b6a770e7d71736fbe99fccda_v2"}